I look at $50m MC and think it is still peanuts with two fantastic phase 2 trials happening with potential markets with many zeros.
Am I the only gorilla gouging on this thought ?
Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received, page-25
-
- There are more pages in this discussion • 173 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.015(4.48%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 36.0¢ | 33.3¢ | $2.187M | 6.301M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 95422 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 154123 | 12 |
View Market Depth
| Last trade - 14.18pm 26/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
